COMMUNIQUÉS West-GlobeNewswire

Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy
26/05/2026
Urges Stockholders to Vote “ FOR ” the Election of Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today BRISBANE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the “Company [...]
LENZ Therapeutics to Participate in Upcoming Investor Conferences
26/05/2026
SAN DIEGO, May 26, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine ophthalmologic solution) 1.44 [...]
Nu-Tek BioSciences Fuels Animal-Free Raw Materials Revolution, Joins Minnesota Pavilion #4507 at BIO 2026
26/05/2026
Nu-Tek BioSciences joins the MN DEED Minnesota Pavilion at BIO, June 22-25 in San Diego, CA, offering biotech innovators a blueprint for scalable, animal-free manufacturing through its product portfolio and Variability [...]
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation
26/05/2026
Revenue increasing 207% at a 32% CAGR: From $65.3 million in 2025 to $200.6 million by 2029, driven by strong growth across all core segments Gross profit growing 801% to $71.2M: Margins expanding from 12.1% to 35.5% — [...]
Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access
26/05/2026
- Dialysis access requires frequent cannulation, often exceeding 300 needle punctures annually - - The ATEV was observed to maintain long-term structural integrity and self-repair with smooth muscle cell repopulation [...]
J-Star Holding Subsidiary Receives Central Bank of Taiwan Authorization to Initiate $60 Million Sovereign-Backed Financing Framework through Designated Banks for U.S. Solid-State Battery Expansion ($122.5 Million Project)
26/05/2026
Funding framework supports development of a US$122.5 million advanced battery manufacturing facility in Baytown, Texas under YMA(TX) INC. TAICHUNG CITY, Taiwan, May 26, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd [...]
VVT Med Announces First Patients Treated with VVT’s ScleroSafe™ System in Italy
26/05/2026
Leading Italian Vein Specialist Dr. Luca Palombi and His Team Successfully Treat First Patients in Italy Using the ScleroSafe™ System VANCOUVER, BC, May 26, 2026 (GLOBE NEWSWIRE) -- VVT Med Inc. (TSXV: VVTM) ("VVT Med" [...]
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
26/05/2026
Israel becomes the second jurisdiction and the first outside of the U.S. to grant marketing clearance for the LIBERTY System The AMAR regulatory approval will enable the Company to obtain a Free Sale Certificate to [...]
Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules
26/05/2026
SAN JOSE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and [...]
Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases
26/05/2026
Plus and Harvard analysis shows CNSide enables early diagnosis and better clinical decision-making reducing healthcare costs by 40% Presentation receives blue-ribbon recognition at the ISPOR Annual Meeting, the premier [...]
Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations
26/05/2026
Company Reports Record Early Production Results, Exceeding Yield Targets by 20% ANN ARBOR, Mich., May 26, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig' [...]
MEDX HOLDINGS (MEDH) REPORTS EXCEPTIONAL Q1 2026 FINANCIALS: REVENUE SURGES, EXPANSION ON TRACK, AND CEO TO SPEAK AT HEMP BEVERAGE EXPO
26/05/2026
MedX Holdings and the Lazydaze franchise momentum keeps building - The New Era After Cannabis Rescheduling Austin, Texas , May 26, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MEDX HOLDINGS (MEDH) REPORTS EXCEPTIONAL [...]
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
26/05/2026
Independent DSMB has identified no safety concerns, to date, and recommends continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor Sixth consecutive positive DSMB recommendation [...]
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
26/05/2026
BOSTON, May 26, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Transactions in connection with share buy-back program
26/05/2026
Company announcement no. 18 - 26 26 May 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Novo Nordisk global observational study reveals 2 in 5 people with cardiovascular disease have cardiovascular inflammation, increasing their risk of heart attack and stroke
26/05/2026
The Novo Nordisk study POSEIDON – including 18,904 patients across 18 countries - showed that cardiovascular (CV) inflammation remains highly prevalent among people with cardiovascular disease (CVD), despite current [...]
Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress
26/05/2026
Single dose of EDIT-401 achieved ~90% or greater mean reductions in LDL-C, Lp(a), and ApoB in non-human primates Data reinforce differentiated LDLR upregulation approach with rapid, dose-dependent effects on multiple [...]
New study finds over a third of young men at risk of gambling related harm; fathers disproportionately affected
26/05/2026
VANCOUVER, British Columbia, May 26, 2026 (GLOBE NEWSWIRE) -- Facing economic and financial pressure, new research shows that young men and fathers are at significantly higher risk of problem gambling. This may be [...]
Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors
26/05/2026
– Tumor shrinkage observed in 77% of response-evaluable patients, including in heavily pretreated and KRASi-experienced patients – – ORRs were 67% in PDAC, 50% in NSCLC, and 29% in KRASi-naïve CRC patients – – Results [...]

Pages